Bill Gates’s Pfizer PFE Stock Holding History

Bill Gates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-68,000	Closed	-$2.26M	–	59
2023 Q3	$2.26M	Buy	+68,000	New	+$2.4M	0.01%	59

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bill Gates's PFE Position: Q4 2023 in Review

Bill Gates sold out of Pfizer (PFE) in Q4 2023, closing a stake of 68,000 shares — an estimated $2.26M sold.

Bill Gates first reported a position in PFE in Q3 2023 and held it in 1 quarter. The position peaked at $2.26M in Q3 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Bill Gates reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Bill Gates sold 68,000 Pfizer shares in Q4 2023, an estimated $2.26M.
Bill Gates first reported a position in Pfizer in Q3 2023 and held it in 1 quarter.
Bill Gates's Pfizer position peaked at $2.26M in Q3 2023.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Gates Foundation Trust's 13F filing for Q4 2023, filed 14 Feb 2024.